Announcements Trials

Browse Landscape

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 2 Plasma cell 1 Other neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Gastrointestinal 1 Dermatologic 1 CNS 1

Conditions

Carcinoma, Basal Cell 1

Interventions

Nivolumab 27 pembrolizumab 22 Ipilimumab 17 Temozolomide 13 toripalimab 12 Biopsy 10 Cyclophosphamide 9 Imiquimod 8 Dacarbazine 7 Blood Specimen Collection 7 camrelizumab 6 Chemotherapy, Adjuvant 6 trametinib 5 fludarabine 5 dabrafenib 5 atezolizumab 5 aldesleukin 5 Gene Expression Profiling 5 Cisplatin 5 Aminolevulinic Acid 5 fludarabine phosphate 4 durvalumab 4 binimetinib 4 apatinib 4 Tomography, Optical Coherence 4 Sorafenib 4 Photochemotherapy 4 Interleukin-2 4 Injections 4 Carboplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Patient Reported Outcome Measures × Dermatologic × Clear all

NCT06448936 2025-04-03

FACE-QOL

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡